Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Offer Update

31 Aug 2007 17:10

Babcock International Group PLC31 August 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ORFROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THERELEVANT LAWS OF SUCH JURISDICTION FOR IMMEDIATE RELEASEPRESS ANNOUNCEMENT 31 August 2007 BABCOCK INTERNATIONAL GROUP PLC ("BABCOCK") FINAL CASH OFFER FOR INTERNATIONALNUCLEAR SOLUTIONS PLC ("INS" OR THE "COMPANY") OFFER CLOSED On 9 July 2007, Babcock announced that the Final Cash Offer had becomeunconditional in all respects. As at 3.00 p.m. (London time) on 31 August 2007, Babcock has acquired or hasreceived valid acceptances in respect of a total of 40,205,941 INS Shares,representing approximately 63.6 per cent. of the existing issued share capitalof INS. Of this total: - Babcock owns (other than pursuant to valid acceptances of the Final Cash Offer) 27,954,131 INS Shares, representing approximately 44.2 per cent. of the existing issued share capital of INS; and - Babcock has received valid acceptances for 12,251,810 INS Shares representing approximately 19.4 per cent. of the existing issued share capital of INS (including acceptances pursuant to irrevocable undertakings to accept the Final Cash Offer in respect of a total of 253,904 INS Shares, representing approximately 0.4 per cent. of the existing issued share capital of INS). Final Cash Offer closed The Board of Babcock announces that the Final Cash Offer, which is unconditionalin all respects, has not been extended beyond 31 August 2007 and is therefore nolonger open for acceptance. Settlement Settlement for INS Shareholders who have validly accepted the Final Cash Offerprior to 31 August 2007 will be despatched within 14 days of the relevantacceptance by first class post (in the case of INS Shares held in certificatedform) or credited to the relevant CREST account (in the case of INS Shares heldin uncertificated form). Terms defined in the Offer Document dated 19 June 2007 shall have the samemeaning in this announcement. Enquiries: Babcock Telephone: +44 (0) 20 7291 5000Gordon CampbellPeter RogersBill Tame Hawkpoint (financial adviser to Babcock) Telephone: +44 (0) 20 7665 4500Paul BainesChris Robinson JPMorgan Cazenove (broker to Babcock) Telephone: +44 (0) 20 7588 2828Dermot McKechnie Financial Dynamics (Babcock PR enquiries) Telephone: +44 (0) 20 7269 7221Susanne Yule The release, publication or distribution of this announcement to persons who arenot resident in the United Kingdom may be affected by the laws of the relevantjurisdictions in which they are located. Persons who are not resident in theUnited Kingdom should inform themselves of, and observe, any applicablerequirements. Any failure to comply with such applicable requirements mayconstitute a violation of the securities laws of any such jurisdictions. Hawkpoint, which is authorised and regulated in the United Kingdom by theFinancial Services Authority, is acting exclusively for Babcock and no one elsein connection with the Final Cash Offer and will not be responsible to anyoneother than Babcock for providing the protections afforded to clients ofHawkpoint nor for providing advice in relation to the Final Cash Offer, thecontent of this announcement or any matter referred to herein. JPMorgan Cazenove, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for Babcock and no oneelse in connection with the Final Cash Offer and will not be responsible toanyone other than Babcock for providing the protections afforded to clients ofJPMorgan Cazenove nor for providing advice in relation to the Final Cash Offer,the content of this announcement or any matter referred to herein. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 201610:17 amRNSHolding(s) in Company
23rd Feb 20161:32 pmRNSResult of General Meeting and Director Dealings
12th Feb 20167:00 amRNSInvestor Presentation
5th Feb 20164:47 pmRNSIssue of Equity and Total Voting Rights
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
3rd Feb 20167:00 amRNSPlacing, Posting of Circular and Notice of GM
25th Jan 20167:00 amRNSInnovators & Investors Forum
13th Jan 20167:00 amRNSTrading Update
23rd Dec 20151:15 pmRNSDirector Shareholding and Other Holdings
8th Dec 20153:53 pmRNSIssue of Equity and Total Voting Rights
1st Dec 20157:00 amRNSLogos Earn Out, Issue of Equity and TVR
30th Nov 20155:59 pmRNSHolding(s) in Company
29th Sep 20157:00 amRNSHalf Yearly Report
6th Aug 201511:55 amRNSAdmission of Ordinary Shares
3rd Aug 20157:00 amRNSLogos Third Earn Out Payment & Total Voting Rights
30th Jul 20157:00 amRNSTrading Update and Notice of Interim Results
29th Jul 20157:01 amRNSGrants Under the Long Term Incentive Plan
23rd Jun 20157:00 amRNSInvestor Teach-in
21st May 20154:39 pmRNSHolding(s) in Company
19th May 20151:16 pmRNSResult of AGM
14th May 20157:00 amRNSInstem ALPHADAS Contract Wins
27th Apr 20159:16 amRNSPosting of Annual Report and Notice of AGM
30th Mar 20157:00 amRNSFinal Results
16th Mar 20157:00 amRNSNotice of Results
13th Feb 20157:00 amRNSPerceptive Instruments Earn Out Payment
27th Jan 20157:01 amRNSInnovators & Investors Forum (London)
12th Jan 20157:00 amRNSTrading Update and Notice of Results
23rd Dec 201411:52 amRNSHolding(s) in Company
18th Dec 20147:00 amRNSWIL Research Contract Extension
10th Nov 20147:00 amRNSCentrus-submit Contract Wins
24th Sep 20147:00 amRNSUnaudited Interim Results
5th Sep 20147:00 amRNSNotice of Results
13th Aug 201410:27 amRNSHolding(s) in Company
1st Aug 20147:00 amRNSLogos Second Earn Out Payment
16th Jul 20147:00 amRNSTwo contract wins in Asia-Pacific
21st May 201411:45 amRNSResult of AGM
1st May 20147:00 amRNSContract win
25th Apr 20147:00 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20147:01 amRNSUS Government Contract Extension
26th Mar 20147:00 amRNSFinal Results
6th Mar 20147:00 amRNSNotice of Results
20th Feb 20147:00 amRNSThree-Year SaaS Contract with Leading Pharma
7th Feb 20141:05 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSLogos Initial Earn Out Payment
8th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20137:00 amRNSAcquisition and Trading Update
9th Oct 20137:00 amRNSAppointment of VP Global Sales
25th Sep 20137:00 amRNSHalf Yearly Report
15th Aug 20137:00 amRNSNotice of Results
2nd Jul 20137:00 amRNSFirst Contract Win for Instem Clinical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.